Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study to Evaluate the Leish-111F + MPL-SE Vaccine in the Treatment of Mucosal Leishmaniasis

This study has been completed.
Sponsor:
Collaborator:
Bill and Melinda Gates Foundation
Information provided by:
IDRI
ClinicalTrials.gov Identifier:
NCT00111514
First received: May 20, 2005
Last updated: February 13, 2007
Last verified: February 2007